BL-M24D1

DRUG4 trials

Sponsors

Sichuan Baili Pharmaceutical Co., Ltd.

Conditions

Gastrointestinal TumorsHead and Neck Squamous Cell CarcinomaHematologic MalignanciesMultiple MyelomaNon Small Cell Lung CancerSolid TumorSolid Tumors

Phase 1

A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

RecruitingNCT07232524

Sichuan Baili Pharmaceutical Co., Ltd.Head and Neck Squamous Cell Carcinoma, Solid Tumor

Start: 2025-12-10End: 2027-11-30Target: 16Updated: 2025-12-31

A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors

RecruitingNCT07232420

Sichuan Baili Pharmaceutical Co., Ltd.Non Small Cell Lung Cancer, Solid Tumor

Start: 2025-11-11End: 2027-12-31Target: 33Updated: 2025-11-24

A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies

RecruitingNCT07255898

Sichuan Baili Pharmaceutical Co., Ltd.Hematologic Malignancies, Multiple Myeloma

Start: 2026-03-25End: 2027-12-01Target: 33Updated: 2026-06-04

A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

RecruitingNCT07279428

Sichuan Baili Pharmaceutical Co., Ltd.Gastrointestinal Tumors, Solid Tumors

Start: 2026-01-12End: 2027-12-01Target: 33Updated: 2026-02-27